FOS
Sponsors
St. Joseph's Hospital and Medical Center, Phoenix, Asker & Baerum Hospital, Institut Pasteur de Lille, Hospital Universitari Vall d'Hebron Research Institute, Kaleido Biosciences
Conditions
Crohn DiseaseGlycaemiaHealthyHypoglycemiaIgA NephropathyOverweight or Obesity
Phase 3
Unknown Phase
Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide
CompletedNCT00802971
Start: 2008-12-31End: 2009-06-30Updated: 2009-11-17
Glycaemic and Insulinaemic Responses After Consumption of FOS.
CompletedNCT02353403
Start: 2014-01-31End: 2014-02-28Updated: 2015-02-02
Glycaemic and Insulinaemic Responses After Consumption of FOS.
CompletedNCT02352857
Start: 2013-10-31End: 2014-02-28Updated: 2015-02-02
Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
CompletedNCT02539849
Start: 2014-12-31End: 2017-12-19Updated: 2018-01-31
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
CompletedNCT02628678
Start: 2015-11-30End: 2015-12-31Updated: 2016-08-30
Study to Evaluate the Tolerability of Prebiotics on the Microbiota
CompletedNCT02628652
Start: 2015-10-31End: 2015-12-31Updated: 2016-02-24
Berries, Inflammation, and Gut Microbiome
Active, not recruitingNCT04100200
Start: 2019-10-07End: 2026-10-01Updated: 2026-03-25